Ruoya Li

980 total citations
16 papers, 773 citations indexed

About

Ruoya Li is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Ruoya Li has authored 16 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Ruoya Li's work include Drug Transport and Resistance Mechanisms (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Ruoya Li is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Ruoya Li collaborates with scholars based in France, Germany and Switzerland. Ruoya Li's co-authors include Christiane Guguen‐Guillouzo, Christophe Chesné, André Guillouzo, Sébastien Anthérieu, Sandrine Camus, Agustín Lahoz, Jouko Uusitalo, Ari Tolonen, Miia Turpeinen and Ahmad Sharanek and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Scientific Reports.

In The Last Decade

Ruoya Li

15 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruoya Li France 12 294 242 211 150 134 16 773
B. O. Depelchin Belgium 6 266 0.9× 176 0.7× 88 0.4× 169 1.1× 70 0.5× 7 714
Gregor Tuschl Germany 9 300 1.0× 397 1.6× 290 1.4× 411 2.7× 81 0.6× 14 1.1k
María José Gómez Lechón Spain 4 153 0.5× 252 1.0× 154 0.7× 208 1.4× 34 0.3× 7 587
Atsuko Miyajima Japan 19 498 1.7× 130 0.5× 171 0.8× 53 0.4× 137 1.0× 47 917
Eliane Alexandre France 18 204 0.7× 307 1.3× 183 0.9× 391 2.6× 44 0.3× 31 945
Sabrina Moro United Kingdom 5 164 0.6× 197 0.8× 97 0.5× 311 2.1× 63 0.5× 6 740
Malin Darnell Sweden 11 162 0.6× 220 0.9× 99 0.5× 191 1.3× 21 0.2× 15 564
Marwa Hassan Egypt 16 317 1.1× 98 0.4× 108 0.5× 64 0.4× 176 1.3× 55 806
Jiaxin Li China 16 310 1.1× 97 0.4× 189 0.9× 22 0.1× 113 0.8× 81 806
Yin‐Kwan Wong China 13 505 1.7× 106 0.4× 85 0.4× 31 0.2× 132 1.0× 28 965

Countries citing papers authored by Ruoya Li

Since Specialization
Citations

This map shows the geographic impact of Ruoya Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruoya Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruoya Li more than expected).

Fields of papers citing papers by Ruoya Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruoya Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruoya Li. The network helps show where Ruoya Li may publish in the future.

Co-authorship network of co-authors of Ruoya Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ruoya Li. A scholar is included among the top collaborators of Ruoya Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruoya Li. Ruoya Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Graf, Katja, et al.. (2023). Evaluation of drug-induced liver toxicity of trovafloxacin and levofloxacin in a human microphysiological liver model. Scientific Reports. 13(1). 13338–13338. 13 indexed citations
2.
Ma, Yulong, et al.. (2018). Plasma synthesis of Pt nanoparticles on 3D reduced graphene oxide-carbon nanotubes nanocomposites towards methanol oxidation reaction. Applied Surface Science. 450. 413–421. 36 indexed citations
3.
Garnier, Delphine, Ruoya Li, Frédéric Delbos, et al.. (2018). Expansion of human primary hepatocytes in vitro through their amplification as liver progenitors in a 3D organoid system. Scientific Reports. 8(1). 8222–8222. 52 indexed citations
4.
Rougier, Nathalie, Yann Pellequer, Alf Lamprecht, et al.. (2018). Interspecies differences in the cytochrome P450 activity of hepatocytes exposed to PLGA and silica nanoparticles: anin vitroandin vivoinvestigation. Nanoscale. 10(11). 5171–5181. 11 indexed citations
5.
Sharanek, Ahmad, Audrey Burban, Rémy Le Guével, et al.. (2016). Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs. Scientific Reports. 6(1). 24709–24709. 62 indexed citations
6.
Sharanek, Ahmad, Audrey Burban, Ruoya Li, et al.. (2015). Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes. Toxicological Sciences. 145(1). 157–168. 60 indexed citations
7.
Doktorova, Tatyana Y., Liesbeth Ceelen, Mireia Vilardell, et al.. (2014). Testing chemical carcinogenicity by using a transcriptomics HepaRG-based model?. PubMed. 13. 623–37. 19 indexed citations
8.
Doktorova, Tatyana Y., Mathieu Vinken, Mireia Vilardell, et al.. (2013). Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models. Carcinogenesis. 34(6). 1393–1402. 42 indexed citations
9.
Anthérieu, Sébastien, Christophe Chesné, Ruoya Li, Christiane Guguen‐Guillouzo, & André Guillouzo. (2012). Optimization of the HepaRG cell model for drug metabolism and toxicity studies. Toxicology in Vitro. 26(8). 1278–1285. 139 indexed citations
10.
Kotani, Naoki, Kazuya Maeda, Sandrine Camus, et al.. (2012). Expression and Transport Function of Drug Uptake Transporters in Differentiated HepaRG Cells. Molecular Pharmaceutics. 9(12). 3434–3441. 43 indexed citations
11.
Madigou, Thierry, et al.. (2011). Fully Automated Microinjection System for Xenopus laevis Oocytes with Integrated Sorting and Collection. JALA Journal of the Association for Laboratory Automation. 16(3). 186–196. 10 indexed citations
12.
Anthérieu, Sébastien, Christophe Chesné, Ruoya Li, et al.. (2009). Stable Expression, Activity, and Inducibility of Cytochromes P450 in Differentiated HepaRG Cells. Drug Metabolism and Disposition. 38(3). 516–525. 218 indexed citations
14.
Frit, Philippe, et al.. (2000). Ku Entry into DNA Inhibits Inward DNA Transactions in Vitro. Journal of Biological Chemistry. 275(46). 35684–35691. 20 indexed citations
15.
Li, Ruoya, Patrick Calsou, Christopher J. Jones, & Bernard Salles. (1998). Interactions of the transcription/DNA repair factor TFIIH and XP repair proteins with DNA lesions in a cell-free repair assay. Journal of Molecular Biology. 281(2). 211–218. 46 indexed citations
16.
Vries, Luc De, Ruoya Li, Ashraf Ragab, Jeannie M.F. Ragab-Thomas, & Hugues Chap. (1991). Expression of a truncated protein‐tyrosine phosphatase mRNA in human lung. FEBS Letters. 282(2). 285–288. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026